Pharma Mar (PHMMF)

Last Closing Price: --

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Pharma Mar (PHMMF) had Net Income of $84.84M for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$250.48M
Net Income
$84.84M
$13.87M
$236.61M
$181.79M
$68.69M
$-1.20M
$67.49M
$67.49M
$84.84M
$84.84M
$84.84M
$84.84M
$68.69M
$77.77M
17.43M
17.45M
$4.87
$4.87
Balance Sheet Financials
$320.66M
$64.93M
$126.34M
$446.99M
$106.21M
$40.22M
$55.86M
$162.07M
$284.92M
$280.91M
$284.92M
17.36M
Cash Flow Statement Financials
$60.11M
$-68.78M
$-41.32M
$71.55M
$20.16M
$-51.39M
$2.32M
$-15.78M
--
Fundamental Metrics & Ratios
3.02
--
--
0.12
0.18
94.46%
27.42%
27.42%
31.05%
26.94%
33.87%
$52.80M
--
--
--
0.56
0.23
5.62
64.97
29.78%
30.20%
18.98%
26.09%
$16.41
$3.03
$3.44